NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), has filed its quarterly report with the Securities and Exchange Commission on Friday, May 20th, in a timely fashion. The Company reported that it had approximately $7.763M in cash and approximately $523,000 in prepaid expenses and other cash equivalent assets as of March 31, 2010, the end of the reporting quarter. The shareholder equity stood at approximately $9.048M. In comparison, the Company had approximately $9M in cash, $560,000 in prepaid expenses and other cash equivalent assets, and $9.367M in shareholder equity as of the quarter ended December 31, 2010. The Company spent approximately $1.65M in Research and Development expenses (R&D) and approximately $863,000 in General and Administrative expenses (G&A) in the reported quarter. The Company’s rate of cash expenditure was in line with the Company’s budgeted targets.
